The Medical Letter on Drugs and Therapeutics, commonly referred to as The Medical Letter, provides independent, unbiased critical evaluations of new drugs and sometimes older drugs when important new information becomes available. The Medical Letter is well known as the "Gold Standard", for new drug review within the medical community for over five decades.
The Medical Letter has a print and electronic circulation of well over 450,000 subscribers...
more
The Medical Letter on Drugs and Therapeutics, commonly referred to as The Medical Letter, provides independent, unbiased critical evaluations of new drugs and sometimes older drugs when important new information becomes available. The Medical Letter is well known as the "Gold Standard", for new drug review within the medical community for over five decades.
The Medical Letter has a print and electronic circulation of well over 450,000 subscribers in 125 countries worldwide.
Published biweekly (26 issues/year), the newsletter is available in several languages: English (US and Canadian editions), French (Canadian and European editions), Italian, Japanese, and Spanish.The Medical Letter is also available as an electronic site license for institutions such as medical schools, hospitals and group practices.
The Medical Letter is published by The Medical Letter, Inc., which also publishes the monthly Treatment Guidelines from The Medical Letter.
An expert consultant or one of the editors...
less
